A Potential Biomarker of Dynamic Change in Peripheral CD45RA(−)CD27(+)CD127(+) Central Memory T Cells for Anti-PD-1 Therapy in Patients with Esophageal Squamous Cell Carcinoma

SIMPLE SUMMARY: In order to develop a biomarker predicting the efficacy of chemotherapy (CT), chemoradiotherapy (CRT), and nivolumab therapy (NT) for patients with esophageal squamous cell carcinoma (ESCC), we evaluated the subpopulation of T cells in ESCC patients treated with each therapy. The fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakuma, Mei, Mimura, Kosaku, Nakajima, Shotaro, Kaneta, Akinao, Kikuchi, Tomohiro, Nirei, Azuma, Tada, Takeshi, Hanayama, Hiroyuki, Okayama, Hirokazu, Sakamoto, Wataru, Saito, Motonobu, Momma, Tomoyuki, Saze, Zenichiro, Kono, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377516/
https://www.ncbi.nlm.nih.gov/pubmed/37509302
http://dx.doi.org/10.3390/cancers15143641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377516/
https://www.ncbi.nlm.nih.gov/pubmed/37509302
http://dx.doi.org/10.3390/cancers15143641

Ejemplares similares